Schizophrenia Clinical Trials in Houston

Showing 61-80 of 121 trials

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

NCT02975973

Cognitive impairments in schizophrenia are the most debilitating aspect of the illness and poorly treated by current medications. This study investigates transcranial direct current stimulation (tDCS) - a safe, noninvasive weak electrical current delivery to stimulate brain function - as a novel therapeutic for cognition in schizophrenia. Integrating neurostimulation, electrophysiology and neuroimaging, this project aims to study tDCS effects on cognition by verifying therapeutic target engagement, evaluating the tolerability of tDCS sessions, and optimizing treatment parameters.

SchizophreniaPsychosis

Baylor College of Medicine15 participantsStarted Nov 2016

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of Cariprazine in Schizophrenia

NCT01104779

The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.

Schizophrenia

Forest Laboratories446 participantsStarted Apr 2010

Costa Mesa, California, United States • Long Beach, California, United States • Paramount, California, United States +38 more locations

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

Safety and Efficacy of Cariprazine in Schizophrenia

Schizophrenia Trials in Other Cities

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Pediatric Open-Label Extension Study

Pediatric Schizophrenia Efficacy and Safety Study

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

Improving Care and Reducing Cost Study

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia

Study of Efficacy of PEAR-004 in Schizophrenia

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Clozapine for Cannabis Use in Schizophrenia

Other Conditions in Houston